UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lowered by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,922 shares of the healthcare conglomerate’s stock after selling 2,025 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in UnitedHealth Group were worth $4,007,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. International Assets Investment Management LLC raised its stake in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Accredited Investors Inc. boosted its stake in shares of UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after purchasing an additional 776,516 shares during the last quarter. Raymond James & Associates raised its position in shares of UnitedHealth Group by 33.1% in the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its holdings in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after buying an additional 581,324 shares during the period. Finally, State Street Corp grew its stake in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have commented on UNH shares. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

NYSE UNH opened at $539.50 on Thursday. The stock has a market capitalization of $496.49 billion, a PE ratio of 34.81, a P/E/G ratio of 1.48 and a beta of 0.61. The business has a 50 day simple moving average of $533.81 and a two-hundred day simple moving average of $564.94. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the company earned $5.83 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.